Dr. Suarez and Dr. Vorstman are having a seminar on Wednesday, November 11 at 6:00P.M. at the Renaissance Fort Lauderdale at Port Everglades 1617 Southeast 17 Street, Fort Lauderdale, FL 33316 also, on Wednesday, November 18 at 6:00 P.M. at the Biltmore Hotel Miami Stoneman Douglas Amphitheater, 1200 Anastasia Avenue, Coral Gables, Florida CALL 305 595-0199
If you would like to schedule a free 10 minute personal consultation with Dr. Suarez or Dr. Vorstman between 5-6 P.M. or 7-8 P.M.call 305 595-0199 www.hifumedicalexpert.com
Thursday, November 5, 2009
Thursday, October 29, 2009
NEW INSIGHTS
Copy/Paste HTML ArticleBackground & Aims: Radiation therapy for prostate cancer has been associated with an increased rate of pelvic malignancies, particularly bladder cancer. The association between radiation therapy and colorectal cancer has not been established. Methods: We conducted a retrospective cohort study using Surveillance, Epidemiology, and End Results (SEER) registry data from 1973 through 1994. We focused on men with prostate cancer, but with no previous history of colorectal cancer, treated with either surgery or radiation who survived at least 5 years. We evaluated the effect of radiation on development of cancer for 3 sites: definitely irradiated sites (rectum), potentially irradiated sites (rectosigmoid, sigmoid, and cecum), and nonirradiated sites (the rest of the colon). Using a proportional hazards model, we evaluated the effect of radiation on development of colorectal cancer over time. Results: A total of 30,552 men received radiation, and 55,263 underwent surgery only. Colorectal cancers developed in 1437 patients: 267 in irradiated sites, 686 in potentially irradiated sites, and 484 in nonirradiated sites. Radiation was independently associated with development of cancer over time in irradiated sites but not in the remainder of the colon. The adjusted hazards ratio for development of rectal cancer was 1.7 for the radiation group, compared with the surgery-only group (95% CI: 1.4–2.2). Conclusions: We noted a significant increase in development of rectal cancer after radiation for prostate cancer. Radiation had no effect on development of cancer in the remainder of the colon, indicating that the effect is specific to directly irradiated tissue.
Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota, USA
‡ University of Minnesota Comprehensive Cancer Center, Minneapolis, Minnesota
§ Department of Radiation Oncology and the UNC/Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina
¶ Division of Health Services Research and Policy, University of Minnesota School of Public Health, Minneapolis, Minnesota
Address requests for reprints to: Nancy Baxter, MD, PhD, Division of Colon and Rectal Surgery, University of Minnesota, MMC 450, 420 Delaware Street SE, Minneapolis, Minnesota 55455; fax: (612) 626-4915.
Supported by a University of Minnesota Academic Health Center Seed grant.
PII: S0016-5085(04)02333-9
doi:10.1053/j.gastro.2004.12.038
© 2005 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.
Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota, USA
‡ University of Minnesota Comprehensive Cancer Center, Minneapolis, Minnesota
§ Department of Radiation Oncology and the UNC/Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina
¶ Division of Health Services Research and Policy, University of Minnesota School of Public Health, Minneapolis, Minnesota
Address requests for reprints to: Nancy Baxter, MD, PhD, Division of Colon and Rectal Surgery, University of Minnesota, MMC 450, 420 Delaware Street SE, Minneapolis, Minnesota 55455; fax: (612) 626-4915.
Supported by a University of Minnesota Academic Health Center Seed grant.
PII: S0016-5085(04)02333-9
doi:10.1053/j.gastro.2004.12.038
© 2005 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.
Thursday, October 8, 2009
MEN'S HEALTH
--------------------------------------------------------------------------------
Dallas Cowboys Quarterback Tony Romo Tackles Prostate Cancer
(NAPSI)-Superstar quarterback Tony Romo found himself in new territory when he learned that his father was battling cancer. Ramiro Romo had shown no signs or symptoms of the disease when a screening exam revealed he had prostate cancer. The experience shocked and scared his entire family.
Thankfully, the elder Romo's cancer was caught early. Now, Tony and his dad have teamed up with the Prostate Conditions Education Council (PCEC) to urge men to get a prostate cancer screening as part of the national "Tackle Prostate Cancer" program. The Tackle Prostate Cancer program, which includes support from 13 teams around the country, hopes to encourage more than 100,000 men to be screened for prostate cancer over the course of the season.
"Prostate cancer was something we didn't have a lot of knowledge about," says Romo. "We were lucky that Dad found it early and really wanted to spread the word about the importance of screening so that others would have the same advantages."
Nearly 200,000 men will go through a similar experience this year when they are diagnosed with prostate cancer. The disease remains the second-leading cause of cancer death among American men, with more than 27,000 expected to die from it this year. When detected early, the five-year survival rate is nearly 100 percent.
While prostate cancer is often treatable when detected early, there are frequently no warning signs or symptoms in its earliest stages-making early detection and screening crucial for saving lives. For this reason, PCEC and the Romos want men to "Choose to Know-and Know to Choose." This means they should choose to know their PSA values, just as they would their cholesterol and know that there are many choices and variables in determining if they need a biopsy or treatment.
"It is as simple as this-screening saves lives," said E. David Crawford, M.D., head of the Urologic Oncology Department at the University of Colorado Health Sciences Center and founder and chairman of PCEC. "We recommend that all men get a baseline prostate health assessment at 35 years of age and work with their doctors to determine a screening schedule that is right for them."
Men who want to respond to the challenge should visit www.tackleprostatecancer.com to register and receive exclusive access to program information.
Tony Romo and his father encourage men to be screened for prostate cancer.
Download high-resolution, print_quality graphic and MS Word document
--------------------------------------------------------------------------------
Word Count: 393
--------------------------------------------------------------------------------
Copy/Paste HTML Article
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Dallas Cowboys Quarterback Tony Romo Tackles Prostate Cancer
(NAPSI)-Superstar quarterback Tony Romo found himself in new territory when he learned that his father was battling cancer. Ramiro Romo had shown no signs or symptoms of the disease when a screening exam revealed he had prostate cancer. The experience shocked and scared his entire family.
Thankfully, the elder Romo's cancer was caught early. Now, Tony and his dad have teamed up with the Prostate Conditions Education Council (PCEC) to urge men to get a prostate cancer screening as part of the national "Tackle Prostate Cancer" program. The Tackle Prostate Cancer program, which includes support from 13 teams around the country, hopes to encourage more than 100,000 men to be screened for prostate cancer over the course of the season.
"Prostate cancer was something we didn't have a lot of knowledge about," says Romo. "We were lucky that Dad found it early and really wanted to spread the word about the importance of screening so that others would have the same advantages."
Nearly 200,000 men will go through a similar experience this year when they are diagnosed with prostate cancer. The disease remains the second-leading cause of cancer death among American men, with more than 27,000 expected to die from it this year. When detected early, the five-year survival rate is nearly 100 percent.
While prostate cancer is often treatable when detected early, there are frequently no warning signs or symptoms in its earliest stages-making early detection and screening crucial for saving lives. For this reason, PCEC and the Romos want men to "Choose to Know-and Know to Choose." This means they should choose to know their PSA values, just as they would their cholesterol and know that there are many choices and variables in determining if they need a biopsy or treatment.
"It is as simple as this-screening saves lives," said E. David Crawford, M.D., head of the Urologic Oncology Department at the University of Colorado Health Sciences Center and founder and chairman of PCEC. "We recommend that all men get a baseline prostate health assessment at 35 years of age and work with their doctors to determine a screening schedule that is right for them."
Men who want to respond to the challenge should visit www.tackleprostatecancer.com to register and receive exclusive access to program information.
Tony Romo and his father encourage men to be screened for prostate cancer.
Download high-resolution, print_quality graphic and MS Word document
--------------------------------------------------------------------------------
Word Count: 393
--------------------------------------------------------------------------------
Copy/Paste HTML Article
--------------------------------------------------------------------------------
Subscribe to:
Posts (Atom)
